Heart institute seeing patients with rare condition possibly linked to mRNA vaccines

July 05, 2021
a close up of a hand: At least eight people have been admitted to the University of Ottawa Heart Institute with a rare inflammation of the heart muscle known as myocarditis. Most cases of myocarditis are considered low-risk.

The University of Ottawa Heart Institute has admitted at least eight people with a rare condition that may be linked to the two mRNA vaccines produced by Moderna and Pfizer-BioNTech.

The condition, myocarditis, is an inflammation of the heart muscle.

The most common symptoms are chest pain, trouble breathing and sensations of pressure on the chest. Most cases are considered mild, with the condition often going away on its own.

In the unlikely case that the inflammation affects the heart's ability to pump blood, the patient is given anti-inflammatory drugs or steroids.

"We have several new cases," said Dr. Peter Liu, scientific director of the Ottawa Heart Institute.

"And as the vaccination effort increases, we probably will see more cases."

Caroline Quach, chair of the National Advisory Committee in Immunization, said most vaccine-related reports of myocarditis involve men younger than 30 after they've received their second dose.

Firefighting efforts in Lynn Lake, Man.

Feds promise military support as fires continue to spread in B.C.

‘Immigrants of Toronto’ podcast helps newcomers adapt by sharing stories

Toronto hair salon owner excited to return to work after restrictions loosen

CBC Manitoba Weather for Saturday, July 3

Canadian students share their unique graduation celebrations

Record temperatures in the North are melting permafrost

Montreal Canadiens play Game 3 of the Stanley Cup finals in Montreal

Dry forests and high heats threaten Kamloops, B.C.

Son says he couldn’t save parents from Lytton, B.C., fire

Couples opting for smaller weddings even after pandemic

Climate change experts predict fires will only get more extreme in B.C.

Canadian gas prices reach 4-year high

Firefighting efforts in Lynn Lake, Man.

U.S. withdraws from its largest airfield in Afghanistan

Vaccinated adults help keep unvaccinated kids safe, experts say

cbc.ca Logo

cbc.ca Logo

cbc.ca Logo

a sign on the side of a building: A woman walks out of the University of Ottawa Heart Institute last May. The institute has recently admitted eight people with myocarditis, or inflammation of the heart muscle — a rare condition potentially connected to mRNA vaccines.

Men typically experience myocarditis at a higher rate than women. So far, Ontario Public Health isn't noticing that myocarditis is occurring at a higher rate in vaccinated men than what would normally occur in the general population.

While researchers don't yet know whether mRNA vaccines cause the rare condition, Quach said the timing suggests they appear to be related.

"There seems to be a temporal link between administration of the mRNA vaccines — particularly the second dose — and the development of this inflammation of the heart," she said.

"Up until now, it was a minority of cases that needed to be admitted to hospitals," Quach added. "Most of the time, we were admitting these patients for observation more than anything else."

Experts continue to stress that benefits of vaccination outweigh the risks, and Liu said all the Ottawa patients improved fairly quickly.

But he also said it's important to know about any side effects that do exist.

"Be aware of them, so that when they do occur, the individual can alert their health providers or go to the emergency department," Liu said.

An Ottawa Public Health spokesperson said the agency doesn't report statistics about adverse vaccine reactions, but it does forward data on side effects to the province.

Post Advertisement
Post Advertisement